IFP Advisors, Inc - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 130 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 3.37 and the average weighting 0.9%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$000.00%
Q1 2021$000.00%
Q4 2020$0
-100.0%
0
-100.0%
0.00%
Q3 2020$1,000
-97.7%
15
-99.4%
0.00%
-100.0%
Q2 2020$44,000
+2.3%
2,660
-14.9%
0.00%
-25.0%
Q1 2020$43,000
-47.6%
3,126
+23.5%
0.00%
-33.3%
Q4 2019$82,000
+86.4%
2,532
+23.9%
0.01%
+100.0%
Q3 2019$44,000
+1366.7%
2,044
+1741.4%
0.00%
Q4 2018$3,0000.0%1110.0%0.00%
Q3 2018$3,000
-92.7%
111
-92.6%
0.00%
-100.0%
Q2 2018$41,000
-39.7%
1,508
-16.0%
0.00%
-33.3%
Q1 2018$68,0000.0%1,7950.0%0.00%0.0%
Q4 2017$68,0001,795
+10458.8%
0.00%
Q3 2017$0170.0%0.00%
Q2 2017$0170.0%0.00%
Q1 2017$0170.0%0.00%
Q4 2016$0170.0%0.00%
Q3 2016$0170.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 3,300,797$90,046,00033.32%
Aisling Capital LLC 1,990,000$54,287,00011.73%
Foresite Capital Management III, LLC 801,240$21,858,0004.82%
PACIFIC VIEW ASSET MANAGEMENT, LLC 189,857$5,181,0004.12%
AlpInvest Partners B.V. 38,943$1,062,0002.27%
Eventide Asset Management 1,739,000$47,440,0001.74%
Palo Alto Investors LP 1,381,759$37,694,0001.52%
Sofinnova Investments, Inc. 222,295$6,064,0000.54%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 553,000$15,086,0000.54%
EMERALD ADVISERS, LLC 486,666$13,276,0000.49%
View complete list of AIMMUNE THERAPEUTICS INC shareholders